BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16584070)

  • 1. Simultaneous use of weighted logrank and standardized Kaplan-Meier statistics.
    Yang P; Fleming TR
    J Biopharm Stat; 2006; 16(2):241-52. PubMed ID: 16584070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The simultaneous use of weighted logrank and weighted Kaplan-Meier statistics with clustered right-censored data.
    Chi Y; Su PF
    Stat Med; 2010 Jan; 29(1):130-41. PubMed ID: 19827012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple testing procedures based on weighted Kaplan-Meier statistics for right-censored survival data.
    Chi Y
    Stat Med; 2005 Jan; 24(1):23-35. PubMed ID: 15515153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous group sequential analysis of rank-based and weighted Kaplan-Meier tests for paired censored survival data.
    Andrei AC; Murray S
    Biometrics; 2005 Sep; 61(3):715-20. PubMed ID: 16135022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sample size calculation for the weighted rank statistics with paired survival data.
    Jung SH
    Stat Med; 2008 Jul; 27(17):3350-65. PubMed ID: 18205148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonparametric analysis of covariance for hypothesis testing with logrank and Wilcoxon scores and survival-rate estimation in a randomized clinical trial.
    Tangen CM; Koch GG
    J Biopharm Stat; 1999 May; 9(2):307-38. PubMed ID: 10379696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weighted Kaplan-Meier estimators for two-stage treatment regimes.
    Miyahara S; Wahed AS
    Stat Med; 2010 Nov; 29(25):2581-91. PubMed ID: 20799259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of survival distributions in clinical trials: A practical guidance.
    Chen X; Wang X; Chen K; Zheng Y; Chappell RJ; Dey J
    Clin Trials; 2020 Oct; 17(5):507-521. PubMed ID: 32594788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A linear rank test for use when the main interest is in differences in cure rates.
    Gray RJ; Tsiatis AA
    Biometrics; 1989 Sep; 45(3):899-904. PubMed ID: 2790128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procedures for two-sample comparisons with multiple endpoints controlling the experimentwise error rate.
    Lehmacher W; Wassmer G; Reitmeir P
    Biometrics; 1991 Jun; 47(2):511-21. PubMed ID: 1912258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic comparison of Kaplan-Meier proportions: monitoring a randomized clinical trial with a long-term binary endpoint.
    Brittain E; Follmann D; Yang S
    Biometrics; 2008 Mar; 64(1):189-97. PubMed ID: 17680830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empirical power comparison of statistical tests in contemporary phase III randomized controlled trials with time-to-event outcomes in oncology.
    Horiguchi M; Hassett MJ; Uno H
    Clin Trials; 2020 Dec; 17(6):597-606. PubMed ID: 32933339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seamless Phase II/III combination study through response adaptive randomization.
    Wang L; Cui L
    J Biopharm Stat; 2007; 17(6):1177-87. PubMed ID: 18027224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive trial design: a general methodology for censored time to event data.
    Jahn-Eimermacher A; Ingel K
    Contemp Clin Trials; 2009 Mar; 30(2):171-7. PubMed ID: 19130902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Test homogeneity of risk difference across subgroups in clinical trials.
    Zhang L; Yang H; Cho I
    J Biopharm Stat; 2009; 19(1):67-76. PubMed ID: 19127467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving efficiency in clinical trials using auxiliary information: Application of a multi-state cure model.
    Conlon AS; Taylor JM; Sargent DJ
    Biometrics; 2015 Jun; 71(2):460-8. PubMed ID: 25585942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample size determination for comparing several survival curves with unequal allocations.
    Halabi S; Singh B
    Stat Med; 2004 Jun; 23(11):1793-815. PubMed ID: 15160409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Joint modeling of progression-free survival and death in advanced cancer clinical trials.
    Dejardin D; Lesaffre E; Verbeke G
    Stat Med; 2010 Jul; 29(16):1724-34. PubMed ID: 20572123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival analysis, more than meets the eye.
    Lucijanic M; Skelin M; Lucijanic T
    Biochem Med (Zagreb); 2017 Feb; 27(1):14-18. PubMed ID: 28392721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. About an adaptively weighted Kaplan-Meier estimate.
    Plante JF
    Lifetime Data Anal; 2009 Sep; 15(3):295-315. PubMed ID: 19533346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.